# Quality of Life After in Situ IRE in Locally Advanced Pancreatic Cancer

> **NCT02926040** · — · TERMINATED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 14 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **PROCEDURE:** Irreversible electroporation

## Key facts

- **NCT ID:** NCT02926040
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2016-10
- **Primary completion:** 2020-02-25
- **Final completion:** 2020-02-25
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** PI left hospital
- **Last updated:** 2020-02-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02926040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02926040, "Quality of Life After in Situ IRE in Locally Advanced Pancreatic Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02926040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*